The BIC International Conference is traditionally addressed to a relatively narrow selection of medical specialties since it is meant to feature only the most novel advances of basic science and clinical research in haemophilia, rare inherited coagulation disorders, von Willebrand factor and disease, gene therapy and thrombotic microangiopathies.

The BIC Conference has been organized in Italy since 1983 by the Milan Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and has established a strong international reputation among scientists and clinicians working in haemostasis and inherited bleeding disorders.
The 14th edition will continue this long-standing tradition, bringing together a selective and highly focused group of leading international experts to discuss the latest advances in haemophilia, von Willebrand disease, thrombotic microangiopathies and gene therapy. Particular emphasis will be placed on new developments, emerging concepts and recent scientific findings, with invited speakers selected for their expertise and their contribution to advancing the field. The programme will be entirely plenary, allowing all participants to share the same scientific experience and to engage directly with the speakers and with each other.
Alongside invited presentations, a large selection of oral communications, selected from the highest-quality submitted abstracts, will provide an opportunity to showcase novel research and emerging findings from the wider scientific community.
The intimate setting of the meeting will encourage open discussion, exchange of ideas and scientific networking, fostering interactions and collaborations among experts from different countries and areas of haemostasis. The combination of cutting-edge science, leading international expertise and close interaction will continue to make the BIC a focused forum for discussing the developments that are shaping the future of the field.